SEC Form 4 · accession 0001209191-18-058040
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jane D. Englebright
Officer — SVP and Chief Nursing Officer
Period of report
Nov 7, 2018
Accepted (ET)
Nov 9, 2018 · 7:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 7, 2018 | M | 10,000 | $22.95 | A | 16,504 | D | |
| Common Stock | Nov 7, 2018 | F | 4,919 | $141.65 | D | 11,585 | D | |
| Common Stock | Nov 9, 2018 | S | 5,081 | $141.90 | D | 6,504 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightF2 | $22.95 | Nov 7, 2018 | M | 10,000 | D | — | Feb 8, 2022 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013.